- Home
- CC vs DYN Comparison
CC vs DYN Comparison
Compare CC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CC | DYN |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CC | DYN |
|---|---|---|
| Price | $12.94 | $19.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 16 |
| Target Price | $17.00 | ★ $40.25 |
| AVG Volume (30 Days) | 2.4M | ★ 3.3M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.70% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,837,000,000.00 | N/A |
| Revenue This Year | $3.34 | N/A |
| Revenue Next Year | $4.20 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 0.03 | N/A |
| 52 Week Low | $9.13 | $6.36 |
| 52 Week High | $20.12 | $27.59 |
Technical Indicators
Market Signals| Indicator | CC | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 54.29 | 47.95 |
| Support Level | $12.09 | $19.20 |
| Resistance Level | $13.42 | $20.80 |
| Average True Range (ATR) | 0.62 | 1.49 |
| MACD | 0.17 | -0.29 |
| Stochastic Oscillator | 81.64 | 20.70 |
Price Performance
Historical ComparisonAbout CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.